Integral Health Asset Management, LLC — 13F Holdings

2026 Q3  ·  132 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Integral Health Asset Management, LLC maintained a portfolio of 132 distinct positions. The most significant new addition was AMGEN INC, now representing 1.92% of the total fund value. They heavily accumulated shares in REVOLUTION MEDICINES INC, increasing the position by 233.3%. The fund also reduced its exposure to CVS HEALTH CORP by 54.5%.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
132
Quarter
2026 Q3
Top Holding
RVMD (7.9%)
Top 10 Concentration
43.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 132

Integral Health Asset Management, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
RVMD
REVOLUTION MEDI...
Healthcare 7.91% 11.10% #1
Prev: #1
5.2
—
-500,000 -33.3%
P
S
1,000,000 $130,340,100 2023 Q1 13F Filing 2026-09-30 2026-11-16
INSM
INSMED INC
Healthcare 7.83% 6.74% #2
Prev: #2
5.6
—
no change no change
P
S
1,600,000 $128,978,200 2020 Q3 13F Filing 2026-09-30 2026-11-16
EWTX
EDGEWISE THERAP...
Healthcare 5.92% 3.21% #3 2
Prev: #5
5.9
—
400,000 20.0%
P
S
2,400,000 $97,440,000 2024 Q3 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 4.40% 5.38% #4 1
Prev: #3
3.3
—
no change no change
P
S
1,600,000 $72,501,000 2020 Q1 13F Filing 2026-09-30 2026-11-16
MRK
MERCK & CO INC
Healthcare 3.97% 1.78% #5 9
Prev: #14
4.6
—
100,000 28.6%
P
S
450,000 $65,389,500 2020 Q1 13F Filing 2026-09-30 2026-11-16
SRRK
SCHOLAR ROCK HL...
Healthcare 3.68% 1.63% #6 11
Prev: #17
4.5
—
505,000 67.3%
P
S
1,255,000 $60,641,600 2023 Q4 13F Filing 2026-09-30 2026-11-16
CNC
CENTENE CORP DE...
Healthcare 2.83% 0.76% #7 34
Prev: #41
4.1
—
450,000 150.0%
P
S
750,000 $46,590,000 2019 Q4 13F Filing 2026-09-30 2026-11-16
AXSM
AXSOME THERAPEU...
Healthcare 2.80% 2.90% #8 1
Prev: #7
1.6
—
-50,000 -16.7%
P
S
250,000 $46,097,500 2024 Q1 13F Filing 2026-09-30 2026-11-16
VERA
VERA THERAPEUTI...
Healthcare 1.96% 2.97% #9 3
Prev: #6
1.3
—
-250,000 -14.3%
P
S
1,500,000 $32,290,000 2024 Q1 13F Filing 2026-09-30 2026-11-16
AMGN
AMGEN INC
Healthcare 1.92% — #10
Prev: #—
4.3
—
75,000 —
NEW
75,000 $31,613,250 2020 Q2 13F Filing 2026-09-30 2026-11-16
LFST
LIFESTANCE HEAL...
Healthcare 1.90% 1.27% #11 11
Prev: #22
1.3
—
-400,000 -13.3%
P
S
2,600,000 $31,278,000 2021 Q3 13F Filing 2026-09-30 2026-11-16
REGN
REGENERON PHARM...
Healthcare 1.84% 0.99% #12 18
Prev: #30
1.7
—
no change no change
P
S
40,000 $30,330,800 2020 Q2 13F Filing 2026-09-30 2026-11-16
THC
TENET HEALTHCAR...
Healthcare 1.40% 1.22% #13 12
Prev: #25
0.6
—
-75,000 -45.5%
P
S
90,000 $23,000,400 2019 Q4 13F Filing 2026-09-30 2026-11-16
BIIB
BIOGEN INC
Healthcare 1.37% 0.85% #14 18
Prev: #32
1.5
—
no change no change
P
S
100,000 $22,588,000 2020 Q4 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 1.36% 1.23% #15 9
Prev: #24
1.5
—
no change no change
P
S
1,000,000 $22,455,000 2024 Q3 13F Filing 2026-09-30 2026-11-16
CAH
CARDINAL HEALTH...
Healthcare 1.35% 2.81% #16 8
Prev: #8
0.5
—
-200,000 -66.7%
P
S
100,000 $22,250,000 2022 Q3 13F Filing 2026-09-30 2026-11-16
CVS
CVS HEALTH CORP
Healthcare 1.30% 4.49% #17 13
Prev: #4
0.5
—
-600,000 -54.5%
P
S
500,000 $21,422,500 2019 Q4 13F Filing 2026-09-30 2026-11-16
NBIX
NEUROCRINE BIOS...
Healthcare 1.29% 1.00% #18 11
Prev: #29
1.5
—
no change no change
P
S
150,000 $21,276,000 2019 Q4 13F Filing 2026-09-30 2026-11-16
VRTX
VERTEX PHARMACE...
Healthcare 1.27% 0.78% #19 19
Prev: #38
1.5
—
no change no change
P
S
40,000 $20,912,400 2021 Q1 13F Filing 2026-09-30 2026-11-16
ORIC
ORIC PHARMACEUT...
Healthcare 1.23% 0.81% #20 16
Prev: #36
1.0
—
-200,000 -10.5%
P
S
1,700,000 $20,205,000 2025 Q2 13F Filing 2026-09-30 2026-11-16
BBIO
BRIDGEBIO PHARM...
Healthcare 1.20% 0.81% #21 16
Prev: #37
2.5
—
25,000 9.1%
P
S
300,000 $19,740,000 2023 Q3 13F Filing 2026-09-30 2026-11-16
INCY
INCYTE CORP
Healthcare 1.18% — #22
Prev: #—
4.0
—
160,000 —
NEW
160,000 $19,416,000 2019 Q4 13F Filing 2026-09-30 2026-11-16
DFTX
DEFINIUM THERAP...
Healthcare 1.16% 1.02% #23 5
Prev: #28
1.0
—
-50,000 -9.1%
P
S
500,000 $19,030,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
BTSG
BRIGHTSPRING HE...
Healthcare 1.12% 1.52% #24 5
Prev: #19
0.4
—
-225,000 -40.9%
P
S
325,000 $18,443,750 2024 Q3 13F Filing 2026-09-30 2026-11-16
ONC
BEONE MEDICINES...
Healthcare 1.11% — #25
Prev: #—
3.9
—
50,000 —
NEW
50,000 $18,297,000 2020 Q2 13F Filing 2026-09-30 2026-11-16
ROIV
ROIVANT SCIENCE...
Healthcare 1.11% 2.80% #26 17
Prev: #9
1.4
—
no change no change
P
S
2,000,000 $18,285,000 2023 Q3 13F Filing 2026-09-30 2026-11-16
LBRX
LB PHARMACEUTIC...
Healthcare 1.10% 0.19% #27 48
Prev: #75
3.4
—
320,000 213.3%
P
S
470,000 $18,038,600 2025 Q3 13F Filing 2026-09-30 2026-11-16
BDX
BECTON DICKINSO...
Healthcare 1.09% — #28
Prev: #—
3.9
—
100,000 —
NEW
100,000 $17,900,000 2020 Q1 13F Filing 2026-09-30 2026-11-16
BSX
BOSTON SCIENTIF...
Healthcare 1.06% 1.52% #29 11
Prev: #18
0.4
—
-500,000 -55.6%
P
S
400,000 $17,460,000 2019 Q4 13F Filing 2026-09-30 2026-11-16
EW
EDWARDS LIFESCI...
Healthcare 1.05% 2.23% #30 19
Prev: #11
0.4
—
-425,000 -68.0%
P
S
200,000 $17,264,000 2020 Q3 13F Filing 2026-09-30 2026-11-16
ERAS
ERASCA INC
Healthcare 1.01% 0.72% #31 11
Prev: #42
2.4
—
130,000 13.0%
P
S
1,130,000 $16,565,800 2026 Q1 13F Filing 2026-09-30 2026-11-16
ALKS
ALKERMES PLC
Healthcare 0.92% 0.21% #32 42
Prev: #74
3.4
—
275,000 275.0%
P
S
375,000 $15,195,000 2020 Q1 13F Filing 2026-09-30 2026-11-16
MDT
MEDTRONIC PLC
Healthcare 0.92% 0.62% #33 13
Prev: #46
0.9
—
-25,000 -12.5%
P
S
175,000 $15,100,750 2019 Q4 13F Filing 2026-09-30 2026-11-16
GKOS
GLAUKOS CORP
Healthcare 0.90% 0.83% #34 1
Prev: #35
0.4
—
-60,000 -40.0%
P
S
90,000 $14,777,100 2020 Q3 13F Filing 2026-09-30 2026-11-16
EHC
ENCOMPASS HEALT...
Healthcare 0.89% — #35
Prev: #—
3.9
—
120,000 —
NEW
120,000 $14,578,800 2020 Q1 13F Filing 2026-09-30 2026-11-16
NVS
NOVARTIS AG
Healthcare 0.87% 1.24% #36 13
Prev: #23
0.3
—
-100,000 -50.0%
P
S
100,000 $14,257,000 2020 Q1 13F Filing 2026-09-30 2026-11-16
ABSI
ABSCI CORPORATI...
Healthcare 0.85% 0.37% #37 27
Prev: #64
3.3
—
500,000 62.5%
P
S
1,300,000 $14,001,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
DGX
QUEST DIAGNOSTI...
Healthcare 0.78% 1.67% #38 23
Prev: #15
0.3
—
-145,000 -72.5%
P
S
55,000 $12,818,850 2019 Q4 13F Filing 2026-09-30 2026-11-16
ANRO
ALTO NEUROSCIEN...
Healthcare 0.77% 0.52% #39 14
Prev: #53
1.3
—
no change no change
P
S
500,000 $12,765,000 2024 Q4 13F Filing 2026-09-30 2026-11-16
MDGL
MADRIGAL PHARMA...
Healthcare 0.76% 0.53% #40 11
Prev: #51
1.3
—
no change no change
P
S
25,000 $12,599,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
BMY
BRISTOL-MYERS S...
Healthcare 0.76% — #41
Prev: #—
3.8
—
200,000 —
NEW
200,000 $12,480,000 2019 Q4 13F Filing 2026-09-30 2026-11-16
EWTX
EDGEWISE THERAP...
CALL
CALL Option 0.74% — #42
Prev: #—
3.8
—
300,000 —
NEW
300,000 $12,180,000 2024 Q3 13F Filing 2026-09-30 2026-11-16
QURE
UNIQURE NV
Healthcare 0.73% 1.64% #43 27
Prev: #16
0.3
—
-400,000 -44.4%
P
S
500,000 $12,080,000 2019 Q4 13F Filing 2026-09-30 2026-11-16
RYTM
RHYTHM PHARMACE...
Healthcare 0.72% 2.41% #44 34
Prev: #10
0.3
—
-300,000 -54.5%
P
S
250,000 $11,901,875 2024 Q4 13F Filing 2026-09-30 2026-11-16
TEVJF
TEVA PHARMACEUT...
Healthcare 0.72% — #45
Prev: #—
3.8
—
300,000 —
NEW
300,000 $11,880,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
TVTX
TRAVERE THERAPE...
Healthcare 0.71% 0.84% #46 13
Prev: #33
0.3
—
-175,000 -46.7%
P
S
200,000 $11,776,000 2021 Q1 13F Filing 2026-09-30 2026-11-16
PRAX
PRAXIS PRECISIO...
Healthcare 0.71% 0.53% #47 5
Prev: #52
1.3
—
no change no change
P
S
40,000 $11,649,200 2025 Q4 13F Filing 2026-09-30 2026-11-16
N/A
LIVANOVA PLC
Bond/Debt 0.70% — #48
Prev: #—
3.8
—
150,000 —
NEW
150,000 $11,475,000 — 13F Filing 2026-09-30 2026-11-16
WAT
WATERS CORP
Healthcare 0.67% 0.59% #49 2
Prev: #47
0.3
—
-15,000 -37.5%
P
S
25,000 $10,984,750 2024 Q4 13F Filing 2026-09-30 2026-11-16
SRZN
SURROZEN INC
Healthcare 0.63% — #50
Prev: #—
3.8
—
325,000 —
NEW
325,000 $10,458,500 2026 Q3 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 132 holdings

Unlock Full Integral Health Asset Management, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →